Abiraterone acetate (JNJ-212082)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Abiraterone acetate (JNJ-212082), covering 2014-04-17 to 2014-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants [Phase 1]